Biomaterial Database

Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. 1981

D S Kumararatne, and I C MacLennan

The origin of the B cells of splenic marginal zones was studied using transfer experiments in rats depleted of marginal-zone cells. Cyclophosphamide given as a single dose of 500 mg/m2 was used to deplete the marginal zones. Approximately 90% depletion was still apparent 10 days after treatment. Fetal liver cells did not induce rapid repopulation of the marginal zone. Also bone marrow cells from rats depleted of recirculating lymphocytes were inefficient in this respect. Conversely, thoracic duct lymphocytes and bone marrow cells from normal rats were efficient at restoring marginal-zone cell numbers in cyclophosphamide-treated rats. Thoracic duct cells passaged through an irradiated intermediate host and collected from that host's thoracic duct were also efficient at achieving marginal-zone reconstitution. In rats receiving 1000 rd whole body irradiation, which were protected with fetal liver cell transfer, marginal zones did repopulate at about 3 weeks. It is concluded that marginal-zone B cells, after leaving primary lymphoid organs, enter the recirculating pool for a period of at least several days before settling in the marginal zone. The turnover rate of marginal-zone cells was assessed using tritiated thymidine infusion. Most marginal-zone cells were not labeled after 5 days continuous labeling suggesting that the marginal-zone B cells are not rapidly dividing.

UI	MeSH Term	Description	Entries
D007700	Kinetics	The rate dynamics in chemical or physical systems.
D008099	Liver	A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.	Livers
D008297	Male		Males
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D001854	Bone Marrow Cells	Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.	Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002454	Cell Differentiation	Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.	Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002465	Cell Movement	The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.	Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D003520	Cyclophosphamide	Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.	(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260	Female		Females
D005333	Fetus	The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.	Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal